Increased remissions from one course for intermediate-dose cytosine arabinoside and idarubicin in elderly acute myeloid leukaemia when combined with cladribine. A randomized population-based phase II study.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples